Literature DB >> 31179727

Ipsilateral Hypertrophy of the Mastoid Process in Surgical Cases of Congenital Muscular Torticollis.

Hyun Gi Kim1,2, Shin-Young Yim3.   

Abstract

OBJECTIVE: This study was to investigate ipsilateral hypertrophy of the mastoid process in the patients with congenital muscular torticollis (CMT).
DESIGN: Retrospective cross-sectional study. PATIENTS: Children with CMT.
METHODS: A total of 212 surgical cases of patients with CMT (age: 50.9 ± 44.3 months) and 212 age- and gender-matched controls (age: 50.4 ± 44.2 months) were included. The mastoid process volume was calculated and compared for both groups on the computed tomography axial images. A linear regression analysis was performed between the age and the intrasubject volume difference in the mastoid process.
RESULTS: The volume of the mastoid process in the CMT side was significantly larger than that of the non-CMT side in the CMT group (32.2 ± 30.3 cm3 vs 21.9 ± 22.8 cm3; P < .001). In the control group, there was no significant difference between the volume of the right and left mastoid process (21.6 ± 24.6 cm3 vs 21.2 ± 23.8 cm3; P = .472). The intrasubject volume difference in the mastoid process in the CMT group showed a linear increase with the age (adjusted R 2 = 0.286; P < .001), and the volumetric asymmetry of the mastoid process became more severe over age compared to the control group.
CONCLUSION: We showed ipsilateral hypertrophy of the mastoid process in patients with CMT and demonstrated that the volumetric asymmetry increased with age.

Entities:  

Keywords:  complications; facial asymmetry; hypertrophy; mastoid; torticollis/congenital

Mesh:

Year:  2019        PMID: 31179727     DOI: 10.1177/1055665619853966

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  1 in total

1.  The usefulness, reliability, and quality of YouTube video clips on congenital muscular torticollis: A STROBE compliant study.

Authors:  Kil-Yong Jeong; Hyun Jung Lee; Shin-Young Yim
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.